Cardinal Health, Inc. $CAH Shares Sold by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC lowered its holdings in Cardinal Health, Inc. (NYSE:CAH) by 24.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,348 shares of the company’s stock after selling 771 shares during the period. Kingswood Wealth Advisors LLC’s holdings in Cardinal Health were worth $395,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Greykasell Wealth Strategies Inc. purchased a new position in shares of Cardinal Health in the first quarter valued at $26,000. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. GW&K Investment Management LLC boosted its stake in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares during the period. NBC Securities Inc. purchased a new position in shares of Cardinal Health in the first quarter valued at $48,000. Finally, Garde Capital Inc. purchased a new position in shares of Cardinal Health in the first quarter valued at $52,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

NYSE CAH opened at $156.86 on Friday. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The company has a market capitalization of $37.27 billion, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. The company’s fifty day moving average price is $152.09 and its two-hundred day moving average price is $151.09.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the firm posted $1.84 EPS. The company’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insider Buying and Selling

In other news, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the transaction, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock worth $40,489,525. Company insiders own 0.12% of the company’s stock.

Analyst Ratings Changes

CAH has been the subject of several analyst reports. Wells Fargo & Company restated an “overweight” rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Robert W. Baird upped their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Leerink Partners increased their price objective on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Finally, Evercore ISI reduced their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.